Bath & Body Works, Inc. (BBWI) Stock Price & Analysis
Bath & Body Works, Inc. (BBWI) is trading at USD 20.79, down 3.75% today, as of October 23, 2026 at 14:46 UTC (US market open; quotes may be delayed), according to Nexqual market data.
BBWI last closed at USD 21.6; today's session has ranged USD 20.46–21.5 on volume of 1,119,586 shares. Market capitalization is $4.19B, with a 52-week range of USD 14.28–27.4 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 14:47 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BBWI.md
Key facts (BBWI)
- Last four reported quarters (through Aug 1, 2026): revenue $7.21B, net income $781M (10.8% margin), free cash flow $1.03B (SEC filings).
- Valuation: P/E 5.4x (avg 9.6x at the last 3 fiscal year-ends), EV/EBITDA 4.8x, net debt $2.82B.
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $0K; 1 not under a Rule 10b5-1 plan ($0K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Hold (mean 2.83 on a 1–5 scale) (18 analysts), mean target USD 24 (range 17–54).
- Total return with dividends: 1Y -19.8% vs S&P 500 +14.5%; 5Y -65.8% vs S&P 500 +77.2%.
- Next earnings: 2026-11-19, EPS estimate USD 0.11, revenue estimate $1.55B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (BBWI)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $7.88B | $7.56B | $7.43B | $7.31B | $7.29B | $7.21B |
| Gross profit | $3.85B | $3.25B | $3.24B | $3.23B | $3.19B | — |
| Operating income | $2.01B | $1.38B | $1.28B | $1.27B | $1.13B | $1.21B |
| Net income | $1.33B | $800M | $878M | $798M | $649M | $781M |
| EPS (diluted) | $4.88 | $3.43 | $3.84 | $3.61 | $3.11 | — |
| Free cash flow | $1.22B | $816M | $656M | $660M | $865M | $1.03B |
| Gross margin | 48.9% | 43.1% | 43.6% | 44.3% | 43.7% | — |
| Operating margin | 25.5% | 18.2% | 17.3% | 17.3% | 15.4% | 16.7% |
| Net margin | 16.9% | 10.6% | 11.8% | 10.9% | 8.9% | 10.8% |
| Revenue growth | +22.5% | -4.1% | -1.7% | -1.6% | -0.2% | — |
| Cash + short-term investments | $1.98B | $1.23B | $1.08B | $674M | $953M | — |
| Total debt | $4.85B | $4.86B | $4.39B | $3.88B | $3.89B | — |
Fiscal years end Jan. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Aug 1, 2026) (BBWI)
P/E 5.4x · P/S 0.6x · EV/EBITDA 4.8x · EV/Sales 1.0x · P/FCF 4.1x · FCF yield 24.59% · Earnings yield 18.63% · Dividend yield (paid, TTM) 3.86% · Buyback yield (TTM) 3.51% · Net debt $2.82B · EV $7.01B
P/E at fiscal year-ends: Jan 2026 7.0x, Feb 2025 10.0x, Feb 2024 11.9x.
Insider sales (SEC Form 4, open-market, last ~7 months) (BBWI)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-10-16 | Nash Sarah E | Director | 1 | $0K | 0% | No | Too little history (no open-market trades in 2023) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (BBWI)
Consensus Hold (mean 2.83 on a 1–5 scale), 18 analysts; mean target USD 24 (low 17, high 54).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-16 | Argus Research | Reiterated | Hold | |
| 2026-09-09 | BMO Capital | Initiated | Market Perform | $20 |
| 2026-08-27 | Baird | Target lowered | Neutral | $25 → $23 |
| 2026-08-27 | Barclays | Target lowered | Equal-Weight | $23 → $22 |
| 2026-08-27 | UBS | Target lowered | Neutral | $19 → $17 |
| 2026-08-27 | Wells Fargo | Target lowered | Overweight | $26 → $24 |
| 2026-08-27 | Morgan Stanley | Target lowered | Equal-Weight | $22 → $20 |
| 2026-08-18 | JP Morgan | Target raised | Neutral | $22 → $24 |
| 2026-08-18 | Citigroup | Upgrade | Neutral → Buy | $25 |
| 2026-07-28 | Jefferies | Target raised | Hold | $22 → $23 |
| 2026-07-08 | Goldman Sachs | Downgrade | Neutral → Sell | $23 → $19 |
Total return (dividends reinvested) (BBWI)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -19.8% | -65.8% |
| S&P 500 (SPY) | +14.5% | +77.2% |
| Per year | -19.8% | -19.4% |
| Volatility (annualized) | 61.8% | 50.6% |
| Max drawdown | -44.4% (Oct 2025→Nov 2025) | -78.6% (Dec 2021→Nov 2025) |
BBWI company outlook (results filed Aug 26, 2026)
- “Guidance and Continued Progress on Transformation • Delivers Q2 net sales and adjusted earnings per share results above guidance • Second quarter net sales of $1.5 billion, down 2.3%.”
Quoted word-for-word from the SEC 8-K results press release.
BBWI analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Oct 2026) | $0.11 | $0.25 | -56.2% | $1.55B | 17 |
| Next quarter (ends Jan 2027) | $1.72 | $1.83 | -6.2% | $2.66B | 17 |
| Current fiscal year (ends Jan 2027) | $2.70 | $2.65 | +1.9% | $7.10B | 18 |
| Next fiscal year (ends Jan 2028) | $2.78 | $2.86 | -3.0% | $7.22B | 18 |
BBWI options: expected move
Options price a move of about ±14.3% (±$2.93) by Nov 20, 2026, which includes earnings on Nov 19, 2026; the earnings reaction alone is priced at about ±7.1%. Over the last 8 reports the stock moved ±9.8% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 54.2% | ±6.1% |
| Nov 6, 2026 | 14 | 53.4% | ±8.4% |
| Nov 13, 2026 | 21 | 55.5% | ±11.0% |
| Nov 20, 2026 | 28 | 62.9% | ±14.3% |
| Nov 27, 2026 | 35 | 63.9% | ±16.2% |
| Dec 4, 2026 | 42 | 59.0% | ±16.3% |
| Dec 18, 2026 | 56 | 60.6% | ±18.8% |
| Jan 15, 2027 | 84 | 56.8% | ±21.5% |
30-day implied volatility 62.4% vs 54.4% realized over the last 30 trading days. Put/call ratio (volume) 1.13. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 14:47 UTC)
| Price | USD 20.79 |
|---|---|
| Change | ▼ 3.75% (down) |
| Previous Close | USD 21.6 |
| Open | USD 21.12 |
| Day Range | USD 20.46 – 21.5 |
| 52-Week Range | USD 14.28 – 27.4 |
| Volume | 1,119,586 shares |
| Market Cap | $4.19B |
| Exchange | NYQ |
Technical Analysis (BBWI)
Nexqual's technical model rates BBWI "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of October 23, 2026 at 14:47 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 62.1 (neutral) |
| vs SMA50 | Above (USD 18.31) |
| MACD | 0.86 (positive) |
Analyst Ratings (BBWI)
Wall Street analysts rate BBWI "Hold" based on 18 analysts, with a mean price target of USD 24 (range USD 17–54), per Nexqual as of October 23, 2026 at 14:47 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 18 |
| Mean Target | USD 24 |
| High Target | USD 54 |
| Low Target | USD 17 |
| Buy / Hold / Sell | 4 / 13 / 1 |
Earnings (BBWI)
| Next Earnings Date | 2026-11-19 |
|---|---|
| EPS Estimate | USD 0.11 |
| Revenue Estimate | $1.55B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-07-31 | USD 0.62 vs est 0.24 ▲ beat |
| 2026-04-30 | USD 0.32 vs est 0.29 ▲ beat |
| 2026-01-31 | USD 2.05 vs est 1.77 ▲ beat |
| 2025-10-31 | USD 0.35 vs est 0.4 ▼ miss |
Source: Nexqual, October 23, 2026 at 14:47 UTC.
Financials & Fundamentals (BBWI)
| Total Revenue | $7.21B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -2.30% |
| Gross Margin | +43.04% |
| Operating Margin | +9.58% |
| Profit Margin | +10.83% |
| Current Ratio | 1.2 |
| Total Cash | $794.00M |
| Total Debt | $4.74B |
| Free Cash Flow (last four quarters to Aug 2026, SEC 10-Q / 10-K) | $1.03B (14.3% of revenue) |
Source: Nexqual, October 23, 2026 at 14:47 UTC.
Financial Health Score (BBWI)
Nexqual rates Bath & Body Works, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 14:47 UTC.
| Growth | Weak — Revenue -0% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 43%, operating 10% (last 12 months) |
| Balance Sheet | Mixed — $794M cash and investments vs $3.61B debt (Aug 2026, SEC) |
| Cash Flow | Solid — FCF $1.03B (last 4 quarters to Aug 2026, SEC), 14% margin |
| Efficiency | Mixed — No data |
Ownership (BBWI)
| Insider Ownership | +0.53% |
|---|---|
| Institutional Ownership | +106.01% |
| Shares Outstanding | 201.65M |
| Float | 200.75M |
| Short % of Float | +10.23% |
Source: Nexqual, October 23, 2026 at 14:47 UTC.
Leadership (BBWI)
Bath & Body Works, Inc. is led by Daniel Heaf, CEO & Director, per Nexqual as of October 23, 2026 at 14:47 UTC.
| CEO & Director | Daniel Heaf |
|---|---|
| Interim Chief Financial Officer | Tom Javitch |
Major Backers & Investors (BBWI)
Notable institutional backers of Bath & Body Works, Inc. include FMR, LLC, Shaw D.E. & Co., Inc., AQR Capital Management, LLC, according to Nexqual as of October 23, 2026 at 14:47 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 10.44% |
| Shaw D.E. & Co., Inc. | 3.83% |
| AQR Capital Management, LLC | 3.79% |
| Alliancebernstein L.P. | 2.78% |
| Citadel | 2.53% |
| Fidelity | 2.47% |
| American Century Companies Inc | 2.03% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 12.94% |
| BlackRock | 9.63% |
| State Street | 3.54% |
Source: Nexqual, October 23, 2026 at 14:47 UTC.
From Bath & Body Works, Inc.'s Latest SEC 10-K Filing (filed 2026-03-12)
Key Strengths & Strategy (as disclosed to the SEC)
- Our international partner-based, asset-light business model allows us to establish operating standards by owning assortment, pricing architecture, promotions, store designs and real estate approval while our partners make investments and contribute as experts in local real estate, people and practices.
- Our technology roadmap remains on-track, as we enhance our systems and put in place foundational tools to enable more personalization and seamless customer engagement to drive sustainable growth.
Legal & Regulatory Risks (Item 1A, quoted)
- We may be impacted by our vendors' ability to manufacture and deliver products in a timely manner, meet quality standards and comply with applicable laws and regulations.
- We self-insure certain risks and may be impacted by unfavorable claims experience.
- We may be unable to service or refinance our debt or maintain compliance with restrictive covenants in our debt instruments, including our asset-backed revolving credit facility.
- Changes in laws, regulations, standards, technology platform rules or other requirements relating to privacy, cybersecurity and AI, or any actual or perceived failure by us to comply with such laws, regulations, rules or contractual or other obligations relating to data privacy, cybersecurity and AI, could have a material adverse effect on our reputation, results of operations, financial condition and cash flows.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ASO | Academy Sports and Outdoors, In | USD 60.08 | ▼ 2.75% |
| MNSO | MINISO Group Holding Limited | USD 10.13 | ▼ 0.78% |
| RH | RH | USD 137.29 | ▼ 2.04% |
| BOBS | Bob's Discount Furniture, Inc. | USD 16.19 | ▼ 0.74% |
| MUSA | Murphy USA Inc. | USD 536.42 | ▲ 0.81% |
| SBH | Sally Beauty Holdings, Inc. (Na | USD 17.12 | ▼ 2.84% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 14:47 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt